Abnormal expression of WTAP and FTO is significantly related to the progression of CRC, and YTHDC2 and ALKBH5 have been identified as key regulators that independently predict the prognosis of patients with CRC [86]. This evidence concerns the gene YTHDC2 and colorectal carcinoma.